Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device.
about
Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degenerationEnhancement of scleral macromolecular permeability with prostaglandinsBiocompatibility and biodegradation studies of subconjunctival implants in rabbit eyesIntravitreous delivery of the corticosteroid fluocinolone acetonide attenuates retinal degeneration in S334ter-4 rats.Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.Impact on intraocular pressure after 20-mg decanted triamcinolone acetonide (kenalog) injection when using prophylactic antiglaucoma therapy.Sustained subconjunctival protein delivery using a thermosetting gel delivery system.Intraocular pressure after intravitreal injection of triamcinolone acetonide.Intravitreal triamcinolone acetonide for exudative age related macular degeneration.Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management.Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and FollFluocinolone acetonide intravitreal sustained release device--a new addition to the armamentarium of uveitic managementInvestigation of Diffusion Characteristics through Microfluidic Channels for Passive Drug Delivery ApplicationsUveitic Macular Edema: Treatment Update.Recent perspectives in ocular drug delivery.Postoperative outcomes after fluocinolone acetonide implant surgery in patients with birdshot chorioretinitis and other types of posterior and panuveitis.Randomized controlled studies on the efficacy of antiarthritic agents in inhibiting cartilage degeneration and pain associated with progression of osteoarthritis in the rat.Applications of polymers in intraocular drug delivery systemsDesign of an implantable device for ocular drug delivery.Design and in vitro biocompatibility of a novel ocular drug delivery device.The effects of indocyanine green and endoillumination on rabbit retina: an electroretinographic and histological study.Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.Evolution of Intravitreal Therapy for Retinal Diseases - From CMV to CNV: The LXXIV Edward Jackson Memorial Lecture.Intravitreal steroids for the treatment of retinal diseases
P2860
Q24243503-065800E2-3BB2-45C2-9D68-C39842286F1EQ28345276-403CA94B-05DA-4C99-9BE6-78B0ADB92F15Q28479248-2CACC63A-A583-4DA9-BBBB-0DDF091A5465Q34022619-F46682B2-E389-4247-9948-5EEA51A216CDQ34530196-3F732C21-CBFE-4222-AC68-48C4DE95C96DQ34771834-354A540E-FDC5-4C6F-9E8C-ED05982F914DQ34987321-FA589CE9-D9C6-4B33-8FD7-8FE189D2322AQ35590421-BE069946-B1E7-452C-A44F-FD967DEF1CDEQ35590749-EA4657C2-B3AB-410B-91C7-FFFAAC313D7DQ36013578-7D3850F7-E1E1-4067-B0DF-275531F7E721Q36090415-2C0A0386-60F4-45CB-B790-B60D26758EBDQ36920430-54FEF384-80B1-46B2-954E-313F730F0900Q36985582-7CEAA8CC-2A2C-4F7F-81AB-FBB6FAB9B532Q37029324-E46D2B7E-8A73-429E-825D-2A17E73F543EQ37256549-2A57A5BD-FE62-4463-8470-4CCBDBC5CCF3Q37310082-B961181E-676F-49DA-BC81-F8802D685B0CQ38800946-D495EA12-B767-4C1D-BDC8-11555853EC0BQ38904930-957AD36D-B301-4FEE-8717-AB8F5F004CBEQ39564169-D4C3E04C-4027-4170-BA60-313257F8AF12Q39870330-8A3C6765-A443-49BD-BDAC-2AD6D06B389EQ43007071-7DB3817A-13F6-4109-A78E-8E654388F80BQ47442388-795723FC-2B25-461A-978A-973DD9B78817Q47729194-C9AE22DE-297A-429B-AED2-43430A53DFF8Q59101228-F009FBEE-2C4A-4164-A338-2E4701EE6292
P2860
Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Safety and pharmacokinetics of ...... ide sustained delivery device.
@en
Safety and pharmacokinetics of ...... ide sustained delivery device.
@nl
type
label
Safety and pharmacokinetics of ...... ide sustained delivery device.
@en
Safety and pharmacokinetics of ...... ide sustained delivery device.
@nl
prefLabel
Safety and pharmacokinetics of ...... ide sustained delivery device.
@en
Safety and pharmacokinetics of ...... ide sustained delivery device.
@nl
P2093
P1476
Safety and pharmacokinetics of ...... nide sustained delivery device
@en
P2093
P304
P407
P577
2000-10-01T00:00:00Z